Skip to main content

Deprescribing Psychotropic Medications in Aged Care Facilities: The Potential Role of Family Members

  • Conference paper
  • First Online:
GeNeDis 2014

Abstract

There is widespread concern in Australia and internationally at the high prevalence of psychotropic medication use in residential aged care facilities. It is difficult for nurses and general practitioners in aged care facilities to cease new residents’ psychotropic medications when they often have no information about why residents were started on the treatment, when and by whom and with what result. Most existing interventions have had a limited and temporary effect and there is a need to test different strategies to overcome the structural and practical barriers to psychotropic medication cessation or deprescribing. In this chapter, we review the literature regarding psychotropic medication deprescribing in aged care facilities and present the protocol of a novel study that will examine the potential role of family members in facilitating deprescribing. This project will help determine if family members can contribute information that will prove useful to clinicians and thereby overcome one of the barriers to deprescribing medications whose harmful effects often outweigh their benefits. We wish to understand the knowledge and attitudes of family members regarding the prescribing and deprescribing of psychotropic medications to newly admitted residents of aged care facilities with a view to developing and testing a range of clinical interventions that will result in better, safer prescribing practices.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Australian Institute of Health and Welfare (2013) Residential aged care and aged care packages in the community 2011–12 [Online]. http://www.aihw.gov.au/aged-care/residential-and-community-2011-12/. Accessed 11 Feb 2014

  2. Hosia-Randell H, Pitkala K (2005) Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 22(9):793–800

    Article  PubMed  Google Scholar 

  3. Snowdon J, Galanos D, Vaswani D (2011) Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries. Int Psychogeriatr 23(9):1520–1525

    Article  PubMed  Google Scholar 

  4. Rattinger GB, Burcu M, Dutcher SK, Chhabra PT, Rosenberg PB, Simoni-Wastila L et al (2013) Pharmacotherapeutic management of dementia across settings of care. J Am Geriatr Soc 61(5):723–733

    Article  PubMed Central  PubMed  Google Scholar 

  5. Wood-Mitchell A, James IA, Waterworth A, Swann A, Ballard C (2008) Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age Ageing 37(5):547–552

    Article  PubMed  Google Scholar 

  6. Kaur S, Mitchell G, Vitetta L, Roberts MS (2009) Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 26(12):1013–1028

    Article  PubMed  Google Scholar 

  7. Brulhart MI, Wermeille JP (2011) Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm 33(3):549–557

    Article  PubMed  Google Scholar 

  8. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD (2013) Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm 35(1):51–56

    Article  PubMed  Google Scholar 

  9. Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S (2013) People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 61(9):1508–1514

    Article  PubMed  Google Scholar 

  10. Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD (2013) Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 30(10):793–807

    Article  PubMed  Google Scholar 

  11. Woodward M (2003) Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 33(4):323–328

    Google Scholar 

  12. Alexander GC, Sayla MA, Holmes HM, Sachs GA (2006) Prioritizing and stopping prescription medicines. CMAJ 174(8):1083–1084

    Article  PubMed Central  PubMed  Google Scholar 

  13. Ostini R, Hegney D, Jackson C, Williamson M, Mackson JM, Gurman K et al (2009) Systematic review of interventions to improve prescribing. Ann Pharmacother 43(3):502–513

    Article  PubMed  Google Scholar 

  14. Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG (2008) Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 56(10):1946–1952

    Article  PubMed Central  PubMed  Google Scholar 

  15. Le Couteur D, Banks E, Gnjidic D, McLachlan A (2011) Deprescribing. Aust Prescr 34:182–185

    Google Scholar 

  16. Ostini R, Hegney D, Jackson C, Tett SE (2012) Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm 18(1):68–72

    PubMed  Google Scholar 

  17. Scott IA, Gray LC, Martin JH, Mitchell CA (2012) Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med 125(6):529–537e4

    Article  PubMed  Google Scholar 

  18. Draper B, Brodaty H, Low LF (2006) A tiered model of psychogeriatric service delivery: an evidence-based approach. Int J Geriatr Psychiatry 21(7):645–653

    Article  PubMed  Google Scholar 

  19. Hartikainen S, Lonnroos E, Louhivuori K (2007) Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 62(10):1172–1181

    Article  PubMed  Google Scholar 

  20. Taipale HT, Bell JS, Gnjidic D, Sulkava R, Hartikainen S (2012) Sedative load among community-dwelling people aged 75 years or older: association with balance and mobility. J Clin Psychopharmacol 32(2):218–224

    Article  PubMed  Google Scholar 

  21. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS (2007) Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 176(5):627–632

    Article  PubMed Central  PubMed  Google Scholar 

  22. The Royal Australian and New Zealand College of Psychiatrists (2009) Practice Guideline 10: Antipsychotic medications as a treatment of behavioural and psychological symptoms in dementia [Online]. https://www.ranzcp.org/Resources/Statements-Guidelines/Practice-Guidelines.aspx. Accessed 09 Feb 2014

  23. Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML et al (2013) Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev 3:CD007726

    Google Scholar 

  24. O’Connor DW, Griffith J, McSweeney K (2010) Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia. Int Psychogeriatr 22(7):1149–1153

    Article  PubMed  Google Scholar 

  25. Maguire A, Hughes C, Cardwell C, O’Reilly D (2013) Psychotropic medications and the transition into care: a national data linkage study. J Am Geriatr Soc 61(2):215–221

    Article  PubMed  Google Scholar 

  26. Azermai M, Vander Stichele RRH, Van Bortel LM, Elseviers MM (2013) Barriers to antipsychotic discontinuation in nursing homes: an exploratory study. Aging Ment Health 18:346–353. http://dx.doi.org/10.1080/13607863.2013.832732

    Google Scholar 

  27. Hilmer SN, Gnjidic D, Le Couteur DG (2012) Thinking through the medication list—appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician 41(12):924–928

    PubMed  Google Scholar 

  28. The Department of Health (2012) Guiding principles for medication management in residential aged care facilities [Online]. http://www.health.gov.au/internet/main/publishing.nsf/Content/nmp-pdf-resguide-cnt.htm Accessed 09 Feb 2014

  29. Tjia J, Gurwitz JH, Briesacher BA (2012) Challenge of changing nursing home prescribing culture. Am J Geriatr Pharmacother 10(1):37–46

    Article  PubMed Central  PubMed  Google Scholar 

  30. Rovner BW, Edelman BA, Cox MP, Shmuely Y (1992) The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 149(10):1390–1392

    CAS  PubMed  Google Scholar 

  31. Rendina N, Brodaty H, Draper B, Peisah C, Brugue E (2009) Substitute consent for nursing home residents prescribed psychotropic medication. Int J Geriatr Psychiatry 24(3):226–231

    Article  PubMed  Google Scholar 

  32. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H et al (2004) An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 33(6):612–617

    Article  PubMed  Google Scholar 

  33. Nishtala PS, McLachlan AJ, Bell JS, Chen TF (2008) Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 16(8):621–632

    Article  PubMed  Google Scholar 

  34. Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP et al (2001) Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 51(3):257–265

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P et al (2004) An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475]. BMC Health Serv Res 4(1):6

    Article  PubMed Central  PubMed  Google Scholar 

  36. Westbury J, Jackson S, Gee P, Peterson G (2010) An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr 22(1):26–36

    Article  PubMed  Google Scholar 

  37. Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S (2011) A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr 23(8):1260–1269

    Article  PubMed  Google Scholar 

  38. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F et al (2007) Designing and evaluating complex interventions to improve health care. BMJ 334(7591):455–459

    Article  PubMed Central  PubMed  Google Scholar 

  39. National Health and Medical Research Council (2007) National statement on ethical conduct in human research (2007) - Updated December 2013 [Online]. http://www.nhmrc.gov.au/guidelines/publications/e72. Accessed 09 Feb 2014

  40. Alzheimer's Australia (2013) Participate in research [Online]. http://www.fightdementia.org.au/research-publications/clinical-trials--research-projects.aspx. Accessed 09 Feb 2014

  41. Gale NK, Heath G, Cameron E, Rashid S, Redwood S (2013) Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13:117

    Article  PubMed Central  PubMed  Google Scholar 

  42. Cumbler E, Wald H, Kutner J (2010) Lack of patient knowledge regarding hospital medications. J Hosp Med 5(2):83–86

    PubMed  Google Scholar 

Download references

Acknowledgements

This project has been funded by the Lions John Cockayne Memorial Fellowship Trust Fund.

The Lions John Cockayne Memorial Fellowship Trust is jointly funded by Oakleigh Lions Club Elderly Peoples Home Inc. and Monash Health.

Conflicts of Interest: The authors report no conflicts of interest and are alone responsible for the content and writing of this chapter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christos Plakiotis F.R.A.N.Z.C.P. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this paper

Cite this paper

Plakiotis, C., Bell, J.S., Jeon, YH., Pond, D., O’Connor, D.W. (2015). Deprescribing Psychotropic Medications in Aged Care Facilities: The Potential Role of Family Members. In: Vlamos, P., Alexiou, A. (eds) GeNeDis 2014. Advances in Experimental Medicine and Biology, vol 821. Springer, Cham. https://doi.org/10.1007/978-3-319-08939-3_8

Download citation

Publish with us

Policies and ethics